Antiphospohlipid syndrome in obstetrics

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 1, 2012, Pages 65-76

  Danza, Alvaro ^a,b   Ruiz Irastorza, Guillermo ^a   Khamashta, Munther ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

anticardiolipin; antiphospholipid syndrome; aspirin; fetal losses; heparin; lupus anticoagulant; recurrent miscarriages

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; NIFEDIPINE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; TINZAPARIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); DEEP VEIN THROMBOSIS; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MONOTHERAPY; OBSTETRICS; OUTCOME ASSESSMENT; PATHOGENESIS; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK BENEFIT ANALYSIS; SPONTANEOUS ABORTION; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOSIS;

EID: 84856472253     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.10.006     Document Type: Review

References (68)

1. G. Ruiz-Irastorza, M. Crowther, and W. Branch Antiphospholipid syndrome Lancet 376 2010 1498 1509
2. G. Ruiz-Irastorza, M.V. Egurbide, and J. Ugalde High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus Arch Intern Med 164 2004 77 78
3. D. Cohen, S.P. Berger, and G.M. Steup-Beekman Diagnosis and management of the antiphospholipid syndrome BMJ 340 2010 1125 1132
4. R. Cervera, J. Font, and M.A. Khamashta Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients Arthritis Rheum 46 2002 1019 1027 (Pubitemid 34303815)
5. R. Cervera, M.A. Khamashta, and Y. Shoenfeld Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients Ann Rheum Dis 68 2009 1428 1432
6. D.W. Branch, M. Gibson, and R.M. Silver Clinical practice. Recurrent miscarriage N Engl J Med 363 2010 1740 1747
7. R.L. Bick Antiphospholipid syndrome in pregnancy Hematol Oncol Clin North Am 22 2008 107 120
8. D.W. Branch, R.M. Silver, and T.F. Porter Obstetric antiphospholipid syndrome: current uncertainties should guide our way Lupus 19 2010 446 452
9. R.S. Rai, L. Regan, and K. Clifford Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach Hum Reprod 10 1995 2001 2005
10. E.A. Steegers, P. von Dadelszen, and J.J. Duvekot Pre-eclampsia Lancet 376 2010 631 644
11. E.A. Clark, R.M. Silver, and D.W. Branch Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 9 2007 219 225 (Pubitemid 46954780)
12. G.R.V. Hughes Thrombosis, abortion, cerebral disease and the lupus anticoagulant Br Med J 287 1983 1088 1089 (Pubitemid 13011933)
13. J. Alijotas-Reig, and M. Vilardell-Tarres Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 65 2010 39 45
14. J. Alijotas-Reig The complement system as a main actor in the pathogenesis of obstetric antiphospholipid syndrome Med Clin (Barc) 134 2010 30 34
15. S. Stone, M.A. Khamashta, and L. Poston Placentation, antiphospholipid syndrome and pregnancy outcome Lupus 10 2001 67 74 (Pubitemid 32410088)
16. V.M. Holers, G. Girardi, and L. Mo Complement C3 activation is required for antiphospholipid antibody-induced fetal loss J Exp Med 195 2002 211 220 (Pubitemid 34461265)
17. G. Girardi, P. Redecha, and J.E. Salmon Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 2004 1222 1226 (Pubitemid 39540439)
18. G. Girardi, and N. Mackman Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule Lupus 17 2008 931 936
19. J.H. Rand, X.X. Wu, and A.S. Quinn The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis Lupus 19 2010 460 469
20. J.H. Rand, X.X. Wu, and A.S. Quinn Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug Blood 115 2010 2292 2299
21. M. Petri Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective Scand J Rheumatol 25 1996 191 193 (Pubitemid 26273848)
22. G. Ruiz-Irastorza, M.V. Egurbide, and J.I. Pijoan Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus Lupus 15 2006 577 583 (Pubitemid 44661744)
23. D. Erkan, Y. Yazici, and M.G. Peterson A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome Rheumatology (Oxford) 41 2002 924 929
24. S. Miyakis, M.D. Lockshin, and T. Atsumi International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
25. M. Mialdea, S.R. Sangle, and D.P. D'Cruz Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis J Autoimmune Dis 6 2009 3
26. V. Pengo, A. Ruffatti, and S. Iliceto The diagnosis of the antiphospholipid syndrome Pathophysiol Haemost Thromb 35 2006 175 180
27. L. Opatrny, M. David, and S.R. Kahn Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis J Rheumatol 33 2006 2214 2221 (Pubitemid 44749780)
28. A. Ruffatti, P. Bagatella, and V. Pengo Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy Thromb Res 123 2009 482 487
29. A. Ruffatti, A. Calligaro, and A. Hoxha Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome Arthritis Care Res (Hoboken) 62 2010 302 307
30. K. Bramham, B.J. Hunt, and S. Germain Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome Lupus 9 2010 58 64
31. R.H. Derksen, and P.G. de Groot Towards evidence-based treatment of thrombotic antiphospholipid syndrome Lupus 19 2010 470 474
32. R.M. Silver, and C.C. Heuser Stillbirth workup and delivery management Clin Obstet Gynecol 53 2010 681 690
33. B. Giannakopoulos, F. Passam, and Y. Ioannou How we diagnose the antiphospholipid syndrome Blood 115 2009 985 994
34. G. Ruiz-Irastorza, B.J. Hunt, and M.A. Khamashta A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies Arthritis Rheum 57 2007 1487 1495 (Pubitemid 350308848)
35. G. Ruiz-Irastorza, M. Cuadrado, and I. Ruiz-Arruza Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies Lupus 20 2011 206 218
36. M.G. Tektonidou, K. Laskari, and D.B. Panagiotakos Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies Arthritis Rheum 61 2009 29 36
37. M.D. Lockshin, M. Drunzin, and T. Qamar Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody Am J Obstet Gynecol 160 1989 439 443 (Pubitemid 19065395)
38. R.K. Silver, S.N. MacGregor, and J.S. Sholl Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients Am J Obstet Gynecol 169 1993 1411 1417 (Pubitemid 24009170)
39. F.S. Cowchock, E.A. Reece, and D. Balaban Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin Am J Obstet Gynecol 166 1992 1318 1323
40. S. Dendrinos, E. Sakkas, and E. Makrakis Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome Int J Gynaecol Obstet 104 2009 223 225
41. R. Rai, H. Cohen, and M. Dave Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ 314 1997 253 257 (Pubitemid 27047378)
42. R.G. Farquharson, S. Quenby, and M. Greaves Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstet Gynecol 100 2002 408 413 (Pubitemid 35246124)
43. S. Gelber, and J. Salmon Effectiveness of treatments for pregnant women with APS Nat Rev Rheumatol 6 2010 187 189
44. C.A. Laskin, K.A. Spitzer, and C.A. Clark Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial J Rheumatol 36 2009 279 287
45. M. Empson, M. Lassere, and J. Craig Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant Cochrane Database Syst Rev. 2 2005 Apr 18 CD002859
46. A. Mak, M.W. Cheung, and A.A. Cheak Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression Rheumatology (Oxford) 49 2010 281 288
47. P.D. Ziakas, M. Pavlou, and M. Voulgarelis Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis Obstet Gynecol 115 2010 1256 1262
48. C.A. Clark, K.A. Spitzer, and C.A. Laskin Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss Obstet Gynecol 116 2010 997 998
49. M. Petri, and U. Qazi Management of antiphospholipid syndrome in pregnancy Rheum Dis Clin North Am 32 2006 591 607 (Pubitemid 44150583)
50. G. Ruiz-Irastorza, and M.A. Khamashta Antiphospholipid syndrome in pregnancy Rheum Dis Clin N Am 33 2007 287 297 (Pubitemid 46710330)
51. S.M. Bates, I.A. Greer, and I. Pabinger American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 844S 886S (Pubitemid 351892978)
52. H.A. Shehata, C. Nelson-Piercy, and M.A. Khamashta Management of pregnancy in antiphospholipid syndrome Rheum Dis Clin North Am 27 2001 643 659 (Pubitemid 32781421)
53. M. Østensen, M. Khamashta, and M. Lockshin Anti-inflammatory and immunosuppressive drugs and reproduction Arthritis Res Ther 8 2006 209
54. T. Horlocker, D. Wedel, and J. Rowlingson American College of Chest Physicians. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) Reg Anesth Pain Med 35 2010 64 101
55. J. Douketis, P. Berger, and A. Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 299S 339S (Pubitemid 351894915)
56. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green Top Guideline no. 37; November 2009.
57. G. Ruiz-Irastorza, M.A. Khamashta, and C. Nelson-Piercy Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 10 2001 597 600 (Pubitemid 32959272)
58. E. Lefkou, M. Khamashta, and G. Hampson Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity? Lupus 19 2010 3 12
59. D. Le Thi Thuong, N. Tieulié, and N. Costedoat The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women Ann Rheum Dis 64 2005 273 278 (Pubitemid 40193625)
60. L. Duley, S. Meher, and E. Abalos Management of pre-eclampsia BMJ 332 2006 463 468 (Pubitemid 43342046)
61. A.M. Côté, M.A. Brown, and E. Lam Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review BMJ 336 2008 1003 1006 (Pubitemid 351656092)
62. K. Duckitt, and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 2005 565
63. L.M. Askie, L. Duley, D.J. Henderson-Smart PARIS Collaborative Group Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet 369 2007 1791 1798 (Pubitemid 46782996)
64. L. Duley, D.J. Henderson-Smart, and S. Meher Drugs for treatment of very high blood pressure during pregnancy Cochrane Database Syst Rev 3 2006 CD001449
65. L. Magee Treating hypertension in women of child-bearing age and during pregnancy Drug Safety 24 2001 457 474 (Pubitemid 32458080)
66. G. Ruiz-Irastorza, and M.A. Khamashta Lupus and pregnancy: ten questions and some answers Lupus 17 2008 416 420 (Pubitemid 351798719)
67. D. Le Thi Huong, B. Wechsler, and D. Vauthier-Brouzes The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome Rheumatology (Oxford) 45 2006 332 338 (Pubitemid 43372850)
68. J.S. Cnossen, R.K. Morris, and G. ter Riet Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis Can Med Assoc J 178 2008 701 711 (Pubitemid 351441471)